logo

For the Inventor, By the Inventor

Laval, Canada

Bio-mega/boehringer Ingelheim Research Inc.

Calculating rank
USPTO Granted Patents = 18


Forward Citations = 79

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Pierre Louis Beaulieu (8 out of 45 patents)

silverMedal Neil Moss (5 out of 34 patents)

bronzeMedal Paul C Anderson (5 out of 8 patents)

4.  Bruno Simoneau (4 out of 33 patents)

5.  Yvan Guindon (3 out of 46 patents)

6.  Christiane Yoakim (3 out of 44 patents)

7.  Teddy Halmos (3 out of 28 patents)

8.  Julian Adams (3 out of 16 patents)

9.  Raymond Plante (3 out of 7 patents)

10.  Grace L Jung (3 out of 4 patents)

11.  Francedillaois Soucy (3 out of 3 patents)

12.  Pierre Lavallee (2 out of 8 patents)

13.  John DiMaio (2 out of 9 patents)

14.  Sumanas Rakhit (2 out of 10 patents)

15.  Robert Deziel (2 out of 6 patents)


18 patents:

1. 5807870 - Substituted pipecolinic acid derivatives as HIV protease inhibitors (1998-09-15),
2. 5672586 - Herpes ribonucleotide reductase inhibitors (1997-09-30),
3. 5648337 - Antiherpes pentapeptides (1997-07-15),
4. 5614533 - Substituted pipecolinic acid derivatives as HIV protease inhibitors (1997-03-25),
5. 5574015 - Isosteric antiherpes peptide derivatives (1996-11-12),
6. 5565476 - N-(hydroxyethyl)butanediamide derivatives (1996-10-15),
7. 5554634 - N-(hydroxyethyl)butanediamide derivatives (1996-09-10),
8. 5552405 - Substituted pyrrolidine derivatives as HIV protease inhibitors (1996-09-03),
9. 5552384 - Antiherpes compositions and method of use (1996-09-03),
10. 5550291 - Process for key intermediates for HIV protease inhibitors (1996-08-27),
11. 5541163 - Renin inhibiting N-(2-amino-2-oxoethyl)butanediamide derivatives (1996-07-30),
12. 5523315 - N-(hydroxyethyl)butanediamide derivatives (1996-06-04),
13. 5502036 - Antiherpes pentapeptide derivatives having a substituted aspartic acid (1996-03-26),
14. 5484771 - Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus (1996-01-16),
15. 5476841 - Inhibitors of herpes viral ribonucleotide reductase (1995-12-19),
Company Overview
Bio-mega/Boehringer Ingelheim Research Inc. is a prominent player in the biotechnology sector, focusing on the development and manufacturing of innovative solutions in pharmaceuticals and healthcare. The organization specializes in research areas such as biopharmaceuticals, animal health, and human therapeutics, leveraging advanced technologies to address unmet medical needs. Based in Laval, Canada, it plays a significant role in the global landscape of biopharmaceutical research and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

18 Patents

#6 in Laval

#822 in Canada

#34,244 in the World

Laval, CA
Laval, Canada

Bio-mega/boehringer Ingelheim Research Inc.

Forward Citations = 79

26 inventors:

goldMedal Pierre Louis Beaulieu (8 out of 45 patents)

silverMedal Neil Moss (5 out of 34 patents)

bronzeMedal Paul C Anderson (5 out of 8 patents)

4.  Bruno Simoneau (4 out of 33 patents)

5.  Yvan Guindon (3 out of 46 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bio-mega/boehringer Ingelheim Research Inc.. Retrieved from https://idiyas.com/company/bio-mega-boehringer-ingelheim-research

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…